Target intelligence / Profile preview

T helper type 1 cytokine (Th1 cytokine)

Target
Th1 cytokine
Molecular classification
Other
01

Overview

Th1-type cytokines are a group of pro-inflammatory cytokines predominantly produced by T helper type 1 (Th1) cells, a subset of CD4+ T lymphocytes central to the immune response against intracellular pathogens such as viruses and certain bacteria[1][2][3][4]. The principal Th1 cytokines are interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α), and interleukin-2 (IL-2)[1][2][3]. These cytokines activate macrophages, enhance antigen presentation, and promote cytotoxic T lymphocyte responses, collectively driving cell-mediated immunity[1][3][4]. While Th1 activity is vital for pathogen clearance, excessive or dysregulated Th1 cytokine production is implicated in the pathogenesis of several autoimmune and chronic inflammatory diseases, including type 1 diabetes mellitus, multiple sclerosis, rheumatoid arthritis, Crohn’s disease, and others[1][3][4]. Th1-type cytokines are not a single molecular target or receptor but rather a functionally related group of signaling proteins involved in immune regulation. Note: This entry is marked as is_incorrect: true, because "Th1-type cytokines" is *not* a specific molecule or receptor but rather a functional category comprising several cytokines (e.g., IFN-γ, TNF-α, IL-2). For structured information aligned to individual drug targets, it is necessary to specify the particular cytokine (e.g., Interferon-gamma) rather than the generic “Th1-type cytokines” grouping[1][2][3].

Other names
Th1-type cytokinesT helper 1 cytokinetype 1 T helper cytokineTh1 cytokinestype 1 cytokinescell-mediated immunity cytokines
02

Biological functions

Immune responseSignal transductionInflammationActivation of macrophagesPromotion of cytotoxic T cell activity
03

Disease associations

Autoimmune diseaseChronic inflammationInfection (especially intracellular pathogens)Cancer
04

Safety considerations

Excessive Th1 responses may drive autoimmunity and chronic inflammationBalance with Th2/Th17 responses is essential for immune homeostasis
05

Biomarkers

Interferon-gamma (IFN-γ)Tumor necrosis factor-alpha (TNF-α)Interleukin-2 (IL-2)

Beyond the preview

Go deeper on T helper type 1 cytokine (Th1 cytokine).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T helper type 1 cytokine (Th1 cytokine).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call